|
Volumn 53, Issue 9, 2001, Pages 1257-1264
|
Hexarelin - Evaluation of factors influencing oral bioavailability and ways to improve absorption
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE;
CHYMOSTATIN;
DRUG METABOLITE;
EDETIC ACID;
EGTAZIC ACID;
GROWTH HORMONE;
HEXARELIN;
LYSINE;
PROTEINASE;
PROTEINASE INHIBITOR;
TRIPLEX III;
TRYPSIN;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CELL STRAIN CACO 2;
DEAMINATION;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG ANTAGONISM;
DRUG BIOAVAILABILITY;
DRUG DEGRADATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG STABILITY;
GROWTH HORMONE BLOOD LEVEL;
GROWTH HORMONE RELEASE;
ILEUM;
INHIBITION KINETICS;
INTESTINE ABSORPTION;
INTESTINE MUCOSA PERMEABILITY;
NONHUMAN;
RAT;
ADMINISTRATION, ORAL;
ANIMALS;
BIOLOGICAL AVAILABILITY;
CATTLE;
CHEMISTRY, PHARMACEUTICAL;
ENDOPEPTIDASES;
HUMANS;
ILEUM;
INTESTINAL ABSORPTION;
OLIGOPEPTIDES;
PERMEABILITY;
RATS;
SWINE;
TRYPSIN;
|
EID: 0034807807
PISSN: 00223573
EISSN: None
Source Type: Journal
DOI: 10.1211/0022357011776540 Document Type: Article |
Times cited : (7)
|
References (24)
|